148 related articles for article (PubMed ID: 18359425)
1. The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study.
Joffe AR; Muscedere J; Marshall JC; Su Y; Heyland DK;
J Crit Care; 2008 Mar; 23(1):82-90. PubMed ID: 18359425
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of diagnostic techniques for ventilator-associated pneumonia.
Canadian Critical Care Trials Group
N Engl J Med; 2006 Dec; 355(25):2619-30. PubMed ID: 17182987
[TBL] [Abstract][Full Text] [Related]
3. Utility of Gram stain in the clinical management of suspected ventilator-associated pneumonia. Secondary analysis of a multicenter randomized trial.
Albert M; Friedrich JO; Adhikari NK; Day AG; Verdant C; Heyland DK;
J Crit Care; 2008 Mar; 23(1):74-81. PubMed ID: 18359424
[TBL] [Abstract][Full Text] [Related]
4. Utility of preliminary bronchoalveolar lavage results in suspected ventilator-associated pneumonia.
Swanson JM; Wood GC; Croce MA; Mueller EW; Boucher BA; Fabian TC
J Trauma; 2008 Dec; 65(6):1271-7. PubMed ID: 19077612
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.
Heyland DK; Dodek P; Muscedere J; Day A; Cook D;
Crit Care Med; 2008 Mar; 36(3):737-44. PubMed ID: 18091545
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumonia.
Raghavendran K; Wang J; Belber C; Misra SR; Brunton K; Berbary E; Burke MS; Haas CE
J Trauma; 2007 Jun; 62(6):1377-82; discussion 1382-3. PubMed ID: 17563652
[TBL] [Abstract][Full Text] [Related]
7. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia.
Mueller EW; Croce MA; Boucher BA; Hanes SD; Wood GC; Swanson JM; Chennault SK; Fabian TC
J Trauma; 2007 Dec; 63(6):1329-37; discussion 1337. PubMed ID: 18212657
[TBL] [Abstract][Full Text] [Related]
8. [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].
Fekih Hassen M; Ayed S; Ben Sik Ali H; Gharbi R; Marghli S; Elatrous S
Ann Fr Anesth Reanim; 2009 Jan; 28(1):16-23. PubMed ID: 19097848
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
[TBL] [Abstract][Full Text] [Related]
10. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
[TBL] [Abstract][Full Text] [Related]
11. Determinants of outcome in patients with a clinical suspicion of ventilator-associated pneumonia.
Muscedere JG; McColl C; Shorr A; Jiang X; Marshall J; Heyland DK;
J Crit Care; 2008 Mar; 23(1):41-9. PubMed ID: 18359420
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy.
Gursel G; Aydogdu M; Ozyilmaz E; Ozis TN
J Crit Care; 2008 Mar; 23(1):34-40. PubMed ID: 18359419
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J
Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
[TBL] [Abstract][Full Text] [Related]
14. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C
Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of ventilator-associated pneumonia.
Medford AR; Husain SA; Turki HM; Millar AB
J Crit Care; 2009 Sep; 24(3):473.e1-6. PubMed ID: 19327300
[TBL] [Abstract][Full Text] [Related]
17. Previous cultures are not clinically useful for guiding empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial.
Sanders KM; Adhikari NK; Friedrich JO; Day A; Jiang X; Heyland D;
J Crit Care; 2008 Mar; 23(1):58-63. PubMed ID: 18359422
[TBL] [Abstract][Full Text] [Related]
18. Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia.
Bouza E; Torres MV; Radice C; Cercenado E; de Diego R; Sánchez-Carrillo C; Muñoz P
Clin Infect Dis; 2007 Feb; 44(3):382-7. PubMed ID: 17205445
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia.
Morris AC; Kefala K; Simpson AJ; Wilkinson TS; Everingham K; Kerslake D; Raby S; Laurenson IF; Swann DG; Walsh TS
Thorax; 2009 Jun; 64(6):516-22. PubMed ID: 19213771
[TBL] [Abstract][Full Text] [Related]
20. Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial.
Shorr AF; Cook D; Jiang X; Muscedere J; Heyland D;
J Crit Care; 2008 Mar; 23(1):64-73. PubMed ID: 18359423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
